Czasopismo
Tytuł artykułu
Autorzy
Warianty tytułu
Języki publikacji
Abstrakty
A multi-element analytical method based on inductively coupled plasma atomic emission spectrometry (ICP-AES) was developed for trace elements in pharmaceutical tablets and cosmetics. Titanium was also included in the analytes since it is widely used in pharmaceuticals. Critical ICP conditions, like RF incident power, argon gas flow rate and nebulizer sample uptake flow rate were optimized. The most sensitive spectral line of each analyte was selected as optimum for further study. Detection limits in the low µg g−1 range were obtained. Prior to chemical analysis, the samples were decomposed by acid digestion, using various mixtures of HCl, HNO3 and HF. Yttrium was used as a suitable internal standard in order to correct for possible matrix effects. The method was applied to the analysis of six different pharmaceutical products (anti-biotic, anti-inflammatory, anti-hypertensive) in the form of tablets with film coating and also three cosmetic products like hair and face masks.
Czasopismo
Rocznik
Tom
Numer
Strony
213-217
Opis fizyczny
Daty
wydano
2011-04-01
online
2011-02-17
Twórcy
Bibliografia
- [1] L. St-Onge, E. Kwong, M. Sabsabi, E.B. Vadas, Spectrochim. Acta B 57, 1131 (2002) http://dx.doi.org/10.1016/S0584-8547(02)00062-9[Crossref]
- [2] Y. Luo, J. Zhu, Y. Ma, H. Zhang, Int. J. Pharma. 358, 16 (2008) http://dx.doi.org/10.1016/j.ijpharm.2008.03.028[Crossref]
- [3] C. Incledon, C. Paquet, A. Johnston, R. Jairam, L. Dass, H. Lam, J. Pharm. Biomed. Anal. 31, 413 (2003) http://dx.doi.org/10.1016/S0731-7085(02)00332-1[Crossref]
- [4] S. Romero-Torres, J.D. Pérez-Ramos, K.R. Morris, E.R. Grant, J. Pharm. Biomed. Anal. 41, 811 (2006) http://dx.doi.org/10.1016/j.jpba.2006.01.033[Crossref]
- [5] Y. Sakata, S. Shiraishi, M. Otsuka, Int. J. Pharm. 317, 120 (2006) http://dx.doi.org/10.1016/j.ijpharm.2006.02.058[Crossref]
- [6] A. Kelko-Levai, I. Varga, K. Zih-Perenyi, A. Lasztity, Spectrochim. Acta B 54, 827 (1999) http://dx.doi.org/10.1016/S0584-8547(99)00036-1[Crossref]
- [7] European Pharmacopoeia 5.0, 5th edition, Section 2.4.8, Heavy metals (European Directorate of Quality of Medicines, Council of Europe, Strasbourg, France, 2005)
- [8] G.A. Zachariadis, D.C. Kapsimali, J. Pharm. Biomed. Anal. 41, 1212 (2006) http://dx.doi.org/10.1016/j.jpba.2006.03.003[Crossref]
- [9] L. Wang, M. Marley, H. Jahansouz, C. Bahnck, J. Pharm. Biomed. Anal. 33, 955 (2003) http://dx.doi.org/10.1016/S0731-7085(03)00364-9[Crossref]
- [10] N. Lewen, S. Mathew, M. Schenkenberger, T. Raglione, J. Pharm. Biomed. Anal. 35, 739 (2004) http://dx.doi.org/10.1016/j.jpba.2004.02.023[Crossref]
- [11] A. Lasztity, A. Kelko-Levai, I. Varga, K. Zih-Perenyi, E. Bertalan, Microchem. J. 73, 59 (2002) http://dx.doi.org/10.1016/S0026-265X(02)00052-8[Crossref]
- [12] J.F. Kauffman, B.J. Westenberger, J. D. Robertson, J. Guthrie, A. Jacobs, S.K. Cummins, Regulatory Toxicol. Pharm. 48, 128 (2007) http://dx.doi.org/10.1016/j.yrtph.2007.03.001[Crossref]
- [13] J. Jürgens, L. Paama, I. Leito, Accred. Qual. Assur. 12, 593 (2007) http://dx.doi.org/10.1007/s00769-007-0299-9[Crossref]
- [14] S. Khalil, M.A. El-Ries, J. Pharm. Biomed. Anal. 27, 117 (2002) http://dx.doi.org/10.1016/S0731-7085(01)00521-0[Crossref]
- [15] G.A. Zachariadis, E. Sahanidou, J. Pharm. Biomed. Anal. 50, 342 (2009) http://dx.doi.org/10.1016/j.jpba.2009.05.003[Crossref]
- [16] G.A. Zachariadis, C. Vogiatzis, Appl. Spectr. Rev. 45, 220 (2010) http://dx.doi.org/10.1080/05704921003719122[Crossref]
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.-psjd-doi-10_2478_s11532-010-0149-1